Inactief instrument

Andere talen GOLD SWAP OTC Bulletin Board

Aandelen

GDSW

US38074W1009

slotkoers OTC Bulletin Board Andere beurzen
- ^USD	-

23/04	Silo Pharma, Inc. Kondigt positieve resultaten aan voor intranasale PTSS-behandeling	CI
10/04	Silo Pharma zegt optie te hebben uitgeoefend om therapeuticum tegen Alzheimer te licentiëren van Columbia University	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention	21/05
Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine	14/05
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment	23/04
Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment	23/04
Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University	10/04
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic	10/04
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.	05/04
Silo Pharma, Inc.'s Equity Buyback Plan Extended till March 31, 2024.	04/04
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.	25/03
Silo Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic	20/03
Silo Pharma, Inc. Exercises Option for Exclusive License Agreement for First-In-Class PTSD and Stress-Induced Anxiety Therapeutic	20/03
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain	18/03
Silo Pharma, Inc. Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain	18/03
Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD	28/02
Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery	14/02
Silo Pharma?s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery	14/02
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology	01/02
Silo Pharma, Inc. Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology	01/02
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study	24/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen GOLD SWAP OTC Bulletin Board

Aandelen

GDSW

US38074W1009

Andere talen

Filters